Bioluminescent Optogenetics: Molecular Control With Biological Light. Questo articolo non è disponibile.
Lingua: inglese
Editore: Springer Nature Switzerland Ag, 2026
- Rilegato
- Nuovo

Da: Revaluation Books, Exeter, Regno UnitoRevaluation Books
Venditore AbeBooks dal 6 gennaio 2003
Condizione: Nuovo
EUR 249,33
Descrizione dell’articolo da parte del venditore
257 pages. 6.45x0.75x9.52 inches. In Stock.
Codice articolo x-3032181208
- Titolo
- Bioluminescent Optogenetics: Molecular Control With Biological Light
- Autore
- Hochgeschwender, Ute (Editor)
- Editore
- Springer Nature Switzerland Ag
- Anno di pubblicazione
- 2026
- Condizione
- Brand New
- Rilegatura
- Hardcover
- Lingua
- inglese
- ISBN 10
- 3032181208
- ISBN 13
- 9783032181206
- Peso dell'articolo
- 0,5 chilogrammi
This book provides an overview of and introduction to the use of bioluminescence for controlling light-sensing molecules. Different from the standard use of bioluminescence in imaging applications in vitro and in vivo, bioluminescent optogenetics harnesses molecularly produced light to activate the wide range of light-controllable modules available, from ion channels to transcription factors. The book covers the principal biological mechanisms of light emission and light sensing and the palette of tools enabled when combining genetically encoded light production with light sensing for use within and across cells. Through examples covering the main applications, Bioluminescent Optogenetics provides a practical guide for using this powerful platform for neuroscience and beyond.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
Ute Hochgeschwender graduated from the Freie Universität in Berlin, Germany, with degrees in medicine (MD) and philosophy (MA). Her research focused on development and application of molecular genetic tools for basic and translational neuroscience. Over the past several years, she established a research program that advances the concept of using biological light, i.e. light generated by a protein, a luciferase, to control light-sensing photoreceptors. An important goal in addition to the continuous development of this BioLuminescent OptoGenetics technology is the application of these tools for research into the mechanisms and potential, non-invasive treatment of neurological and psychiatric diseases.
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.